BULLISH $LITE $AAOI $SIVE $IQE Demand for AI CW lasers is already being locked through 2030. Taiwan’s Landmark just signed a 4-year LTA (2027–2030) with a US customer for data-center CW lasers. This is not a 2027 peak story. This is multi-year supply security in a structural bottleneck. CW lasers (especially higher-power InP) sit at the heart of silicon photonics + CPO. When second-tier suppliers start locking capacity years out, it tells you the majors are already fully booked. Bullish for the entire stack: • $LITE (incumbents sold out) • $AAOI (own lasers + US capacity premium) • $SIVE (high-power CW / arrays pure play) • $IQE (InP epi foundation) The optical layer is booking the decade. The shortage is real. The duration is longer than most think. — Outlier Capital PS: I am long all the stocks mentioned here. Not advice. Many thanks @pequityresearch for the information!

Tomorrow @TemaETFs and $LAZR Expert Advisor A. STORM will have a 30 min X Space, post Sivers Semiconductors $SIVE Q2 2026 earnings call. Book below time slot in your calendars.

Do not doubt this little honey badger of a company. It punches above it's wait, is lead by a team of killers, and operates a bottleneck like one of the Spartans at Thermopylae. Opportunity pipeline continues to expand. The $SIVE growth story is just getting started.

I’m really looking forward to $SIVE earnings report tomorrow. Beyond the headline numbers, reading between the lines will be crucial. I believe we could see at least one additional major deal announced. With production expected to begin in the first half of 2027, I’m also anticipating an update on the planned Nasdaq listing.

@jusmentrades uhh, pretty sure $GFS is a 2027-2028 type optical rerating story... fyi they're like 11.5 fwd p/e ending 2028 and 7.5x longer term, so idk about betting on a 1 1/2 month timeframe in 2026.

In 2025, Sivers delivered 25% full-year revenue growth, with Q4 revenue reaching SEK 80.7 million. Then, in Q1 2026, Sivers reported another important number: its opportunity pipeline had grown 77% year-to-date to $799 million. One looks at what we delivered. The other looks at the opportunity ahead. With our Q2 report coming tomorrow on August 27, catch up on the latest Sivers investor reports here:

$SIVE Breakout done. Ema50 now used as support. EMA200 resistance sitting at 38.28 Earning tomorrow , This one is as exciting as $NVDA because its like one of the leader of the AI Bullrun.

Sivers will publish its Q2 2026 Interim Report tomorrow on August 27. As we head toward Q2, it’s worth looking back at where we left off. In Q1, Sivers reported a 77% YTD increase in its opportunity pipeline to $799 million, while highlighting multiple customer product ramps across Photonics and Wireless expected to drive growth into 2027. Catch up on the Q1 report and investor materials ahead of next week’s update:

$SIVE Consolidation. Sivers been consolidating since the Target 1 been hit. It gave any profit take time to wait the price to hit support and confirm its holding and buyer are showing up. You can see here that the volume on the consolidation been slowing down and both EMA act as support. There is a trade knocking at the door on this ticker and you snipe it when confirmation shows up. The full TA has been posted on the Subs/discord watchlist

$SIVE announces a $3.4M development program with SemiNex! For CPO, DFB laser arrays, and optical amplifiers. Early production is targeted H2 2027 (in line with early scale up CPO timelines) Seemed weird to me at first given product overlap, since SemiNex is a much smaller Series B company... But then I got reminded of a less explicit version of $SPCX + Cursor relationship (derisking by working together first). There's probably something interesting Sivers found in this company.

$AAOI Bouncing price. Price still bouncing over the ema200 4htf which is quite good but even with a massive AI rally day it did not catch a momentum. This is enough for me to tell me to remain patient and wait for a better entry. Waiting for those price highlighted on the charts.

My main takeaway was that your merchant CW laser suppliers seem to be EXTREMELY IMPORTANT now. But TLDR of $COHR earnings: "given the demand that we see in our DC business with transceivers, I don’t see any time in the near future where we would be selling indium phosphide lasers externally" - Ton more value placed on companies that sell InP lasers externally if $AAOI can't doesn't enough capacity for first gen-CPO deployments, $COHR not selling externally... I guess that's why $MTSI said a ton of customers are approaching them with urgency for InP CW DFB lasers (and they dont even have meaningful capacity coming online until EOY 2027) $AAOI -> Internal $COHR -> Internal Buyers -> fewer places to look for capacity. "Our backlog now extends out, fiscal 2027 is basically completely booked out. We are booked really through the end of calendar 2027" [ Massive massive demand visibility] - Coherent also mentioned LTAs spanning end of decade. So this kinda reinforces what $POET CEO said at their AGM that the "big 3" are fully sold out next 2 years. "we’re not constrained in the assembly and test capacity right now. We’re really just constrained by the ramp of the indium phosphide production" - Just for the bottleneck bros in terms of assembly/test not a bottleneck. "absolutely no push-out of CPO demand. In fact, it has been the opposite. We have seen demand increase and request from customers’ demand getting pulled in" "we continue to expect revenue from CPO for scale-up applications to start to flow in the second half of calendar 2027" - Big read through on other CPO players for scale up if $LITE, $COHR reaffirm revenue from CPO scale up coming h2027. - "quarterly revenue exceeding $3 billion by the end of fiscal 2027" - $COHR revenue go brrr So for regular numbers it's: - $2.046B revenue (+13.3% Q/Q, +33.8% Y/Y), main revenue ramp looks to be happening entering Q4 into 2027 - Non-GAAP gross margins: 40.2% Next quarter guide is: - Revenue: $2.2–$2.4B revenue - Non-GAAP gross margins: 39.5-41.5% Basically: $1.69B -> $1.81B -> $2.05B -> ~$2.30B -> $3.0B (end of FY 2027) ~39% -> 39.6% -> 40.2% -> ~40.5% (gross margins) For operating margins: 18.0% -> 19.5% -> 19.9% -> 20.3% -> 21.8% Little less impressed compared to $LITE margin growth in terms of profitability, but revenue scale for $COHR growing rapidly.